SCHEMBL5193555

SCHEMBL5193555

Cc1ccc(S(=O)(=O)Nc2nc(-c3ccccc3)sc2OC(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KDM4E B2RXH2 3/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ ALDH1A1 P00352 6/20 0.46
▸ HPGD P15428 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CA12 O43570 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ MCOLN3 Q8TDD5 1/20 0.45
▸ GAA P10253 3/20 0.45
▸ GLA P06280 1/20 0.45
▸ RORC P51449 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ LIPG Q9Y5X9 1/20 0.44
▸ TTR P02766 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5195752 0.84 ALDH1A1 (0.48) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL5194973 0.83 KMT2A (0.57) KMT2AMEN1KDM4ELMNAMAPT
SCHEMBL3811715 0.75 NPSR1 (0.69) KMT2AMEN1KDM4ELMNANPSR1
SCHEMBL5196570 0.73 MAPT (0.45) KMT2AMAPTNPSR1RXFP1ALDH1A1
SCHEMBL13685249 0.72 SMN1; SMN2 (0.61) KMT2AMEN1KDM4ELMNAMAPT
SCHEMBL634004 0.72 MEN1 (0.75) KMT2AMEN1KDM4ELMNAMAPT
Biphenyl SCHEMBL9176116 0.69 LMNA (0.64) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL5196996 0.68 ADORA3 (0.51) KMT2AMEN1KDM4EMAPTRXFP1
SCHEMBL5196161 0.68 RAB9A (0.46) KMT2AMEN1KDM4ELMNAMAPT
SCHEMBL5194094 0.68 ALDH1A1 (0.53) KMT2AMEN1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1321463-B1 Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections VIROCHEM PHARMA INC (CA) 2007-08-08 — — EP claimed
Send feedback